Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis

被引:11
|
作者
Yamamoto, Kei [1 ,2 ]
Sato, Takao [1 ,2 ]
Salem, Hanan [1 ,2 ,3 ]
Matsumura, Mitsuaki [2 ]
Fall, Khady N. [1 ]
Prasad, Megha [1 ]
Ng, Vivian G. [1 ]
Sethi, Sanjum S. [1 ]
Nazif, Tamim M. [1 ,2 ]
Parikh, Sahil A. [1 ,2 ]
Vahl, Torsten P. [1 ,2 ]
Ali, Ziad A. [2 ,4 ]
Karmpaliotis, Dimitri [2 ,5 ]
Rabbani, LeRoy E. [1 ,2 ]
Collins, Michael B. [1 ,2 ]
Leon, Martin B. [1 ,2 ]
Mcentegart, Margaret [1 ,2 ]
Moses, Jeffery W. [1 ,2 ]
Kirtane, Ajay J. [1 ,2 ]
Mintz, Gary S. [2 ]
Maehara, Akiko [1 ,2 ,6 ]
机构
[1] Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY USA
[2] Cardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA
[3] Tanta Univ, Cardiovasc Med Dept, Fac Med, Tanta, Egypt
[4] St Francis Hosp, Roslyn, NY USA
[5] Morristown Med Ctr, Gagnon Cardiovasc Inst, Morristown, NJ USA
[6] Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 1700 Broadway,9th Floor, New York, NY 10019 USA
关键词
in-stent restenosis; intravascular ultrasound; PCI; DRUG-ELUTING STENTS; 2-YEAR FOLLOW-UP; BALLOON ANGIOPLASTY; IMPLANTATION; PREDICTORS; FRACTURE; INSIGHTS;
D O I
10.4244/EIJ-D-23-00107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite a high rate of in-stent restenosis (ISR) after stenting the right coronary artery (RCA) ostium, the mechanism of ostial RCA ISR is not well understood.Aims: We aimed to clarify the cause of ostial RCA ISR using intravascular ultrasound (IVUS).Methods: Overall, 139 ostial RCA ISR lesions were identified with IVUS, pre-revascularisation. Primary ISR mechanisms were classified as follows: 1) neointimal hyperplasia (NIH); 2) neoatherosclerosis; 3) ostium not covered by the stent; 4) stent fracture or deformation; 5) stent underexpansion (old minimum stent area <4.0 mm2 or stent expansion <50%); or 6) a protruding calcified nodule.Results: The median duration from prior stenting was 1.2 (first quartile 0.6, third quartile 3.1) years. The primary mechanisms of ISR were NIH in 25% (n=35) of lesions, neoatherosclerosis in 22% (n=30), uncov-ered ostium in 6% (n=9) (biological cause 53%, n=74), stent fracture or deformation in 25% (n=35), under -expansion in 11% (n=15), and protruding calcified nodules in 11% (n=15) (mechanical cause 47%, n=65). Including secondary mechanisms, 51% (n=71) of ostial RCA ISRs had stent fractures that were associated with greater hinge motion of the ostial-aorta angle during the cardiac cycle. The Kaplan-Meier rate of target lesion failure at 1 year was 11.5%. When the mechanically caused ISRs were treated without new stents, they suffered a higher subsequent event rate (41.4%) compared with non-mechanical causes or mechanical causes treated without restenting (7.8%, unadjusted hazard ratio 6.44, 95% confidence interval: 2.33-17.78; p<0.0001).Conclusions: Half of the ostial RCA ISRs were due to mechanical causes. Subsequent event rates were high, especially in mechanically caused ISRs treated without the implantation of a new stent.
引用
收藏
页码:E383 / +
页数:25
相关论文
共 50 条
  • [31] Is Coronary Brachytherapy Staging a Comeback for the Treatment of In-Stent Restenosis?
    Htoo Kyaw
    Gurpreet Johal
    Maheedhar Gedela
    Nitin Barman
    Annapoorna Kini
    Samin K. Sharma
    Current Cardiology Reports, 2021, 23
  • [32] In-Stent Restenosis of Innominate Artery with Critical Stenosis of Right Internal Carotid Artery
    Hussain, Sajjad
    Raza, Afsar
    Ahmed, Waqar
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2011, 21 (04): : 239 - 241
  • [33] Association between plasma BMP-2 and in-stent restenosis in patients with coronary artery disease
    Zheng, Wei-ping
    Yang, Min
    Su, Li-xiao
    Ning, Yu
    Wen, Wan-wan
    Xin, Man-kun
    Zhao, Xin
    Zhang, Ming
    CLINICA CHIMICA ACTA, 2017, 471 : 150 - 153
  • [34] Endovascular brachytherapy for renal artery in-stent restenosis
    Silverman, Steven H.
    Exline, Jessica B.
    Silverman, Larry N.
    Samson, Russell H.
    JOURNAL OF VASCULAR SURGERY, 2014, 60 (06) : 1599 - 1604
  • [35] Treatment of in-stent coronary restenosis with excimer laser angioplasty
    Liu, ML
    Chow, WH
    Kwok, OH
    Jim, MH
    Yip, A
    Fan, K
    Chan, E
    CHINESE MEDICAL JOURNAL, 2000, 113 (01) : 14 - 17
  • [36] Treatment of in-stent restenosis with excimer laser coronary angioplasty
    Karaca, I
    Ilkay, E
    Akbulut, M
    Yavuzkir, M
    JAPANESE HEART JOURNAL, 2003, 44 (02): : 179 - 186
  • [37] Treatment of renal artery in-stent restenosis with sirolimus-eluting stents
    Kiernan, Thomas J.
    Yan, Bryan P.
    Eisenberg, Jonathan D.
    Ruggiero, Nicholas J.
    Gupta, Vishal
    Drachman, Douglas
    Schainfeld, Robert M.
    Jaff, Michael R.
    Rosenfield, Kenneth
    Garasic, Joseph
    VASCULAR MEDICINE, 2010, 15 (01) : 3 - 7
  • [38] Prevalence, Management and Outcomes of Percutaneous Coronary Intervention for Coronary In-Stent Restenosis: Insights From the France PCI Registry
    Duband, Benjamin
    Souteyrand, Geraud
    Clerc, Jean Michel
    Chassaing, Stephan
    Fichaux, Olivier
    Marcollet, Pierre
    Deballon, Ronan
    Roussel, Laurent
    Pereira, Bruno
    Collet, Jean-Philippe
    Commeau, Philippe
    Cayla, Guillaume
    Koning, Rene
    Motreff, Pascal
    Benamer, Hakim
    Range, Gregoire
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 52 : 39 - 46
  • [39] Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis
    Drozd, Jakub
    Wojcik, Jaroslaw
    Malek, Robert
    Korona, Beata
    Zapolski, Tomasz
    Wysokinski, Andrzej
    KARDIOLOGIA POLSKA, 2010, 68 (06) : 637 - 645
  • [40] Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery
    Trentmann, J.
    Charalambous, N.
    Djawanscher, M.
    Schaefer, J. -P.
    Jahnke, T.
    JOURNAL OF CARDIOVASCULAR SURGERY, 2010, 51 (04) : 551 - 560